Inovio Strikes $100M Coronavirus Vaccine Licensing Deal With China’s Advaccine

Shares of Inovio Pharmaceuticals Inc (NASDAQ: INO), which is developing a DNA vaccine against the novel coronavirus, were advancing Monday. What Happened: Plymouth …
( read original story …)

---

---